Syra Health Corp. Files Q3 2024 10-Q

TL;DR

Syra Health Corp. 10-Q filed for Q3 2024, showing financial updates.

AI Summary

Syra Health Corp. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the fiscal year. Key financial data and operational details for this period are presented, including information on common stock and preferred stock.

Why It Matters

This filing provides investors with an update on Syra Health Corp.'s financial performance and position as of the end of the third quarter of 2024.

Risk Assessment

Risk Level: medium — As a 10-Q filing, it contains detailed financial information that requires careful analysis to assess the company's health and future prospects.

Key Numbers

• 2024-09-30 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial data is reported.)
• 2024-10-29 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)

Key Players & Entities

• Syra Health Corp. (company) — Filer of the 10-Q
• 2024-09-30 (date) — End of the reporting period
• 2024-10-29 (date) — Filing date
• 7361 (number) — Standard Industrial Classification Code for Employment Agencies

FAQ

Filing Documents

• form10-q.htm (10-Q) — 801KB
• ex31-1.htm (EX-31.1) — 17KB
• ex31-2.htm (EX-31.2) — 18KB
• ex32-1.htm (EX-32.1) — 7KB
• ex32-2.htm (EX-32.2) — 7KB
• 0001493152-24-042875.txt ( ) — 4267KB
• syra-20240930.xsd (EX-101.SCH) — 31KB
• syra-20240930_cal.xml (EX-101.CAL) — 51KB
• syra-20240930_def.xml (EX-101.DEF) — 140KB
• syra-20240930_lab.xml (EX-101.LAB) — 283KB
• syra-20240930_pre.xml (EX-101.PRE) — 228KB
• form10-q_htm.xml (XML) — 525KB

Financial Statements

Financial Statements F-1 Condensed Balance Sheets as of September 30, 2024 (Unaudited) and December 31, 2023 F-1 Condensed Statements of Operations for the Three and Nine Months ended September 30, 2024 and 2023 (Unaudited) F-2 F-3 Condensed Statements of Cash Flows for the Nine Months ended September 30, 2024 and 2023 (Unaudited) F-4 Notes to the Condensed Financial Statements (Unaudited) F-5 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 4 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 11 Item 4.

Controls and Procedures

Controls and Procedures 11

OTHER INFORMATION

PART II. OTHER INFORMATION 12 Item 1.

Legal Proceedings

Legal Proceedings 12 Item 1A.

Risk Factors

Risk Factors 12 Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities 12 Item 3. Defaults Upon Senior Securities 12 Item 5. Other Information 12 Item 6. Exhibits 13

Signatures

Signatures 14 -2- CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA This Quarterly Report on Form 10-Q contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements may be identified by such forward-looking terminology as "may," "should," "expects," "intends," "plans," "anticipates," "believes," "estimates," "predicts," "potential," "continue" or the negative of these terms or other comparable terminology. Our forward-looking statements are based on a series of expectations, assumptions, estimates and projections about our company, are not guarantees of future results or performance and involve substantial risks and uncertainty. We may not actually achieve the plans, intentions or expectations disclosed in these forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in these forward-looking statements. Our business and our forward-looking statements involve substantial known and unknown risks and uncertainties, including the risks and uncertainties inherent in our statements regarding: our projected financial position and estimated cash burn rate; our estimates regarding expenses, future revenues and capital requirements; our ability to continue as a going concern; our need to raise substantial additional capital to fund our operations; our ability to compete in the healthcare industry; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including offerings and pricing; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; compliance with existing laws, regulations and

View Full Filing

View this 10-Q filing on SEC EDGAR